Literature DB >> 10319158

Determination of omeprazole in rat plasma by HPLC with column switching.

S H Shim1, S J Bok, K I Kwon.   

Abstract

A new high-performance liquid chromatographic method with column switching has been developed for the determination of omeprazole in plasma. The plasma samples were injected onto a Bondapak phenyl/corasil (37-50 microns) precolumn and polar plasma components were washed with 0.06 M borate buffer. After valve switching, the concentrated drug were eluted in the back-flush mode and separated on a mu-Bondapak C18 column with acetonitrile-phosphate buffer as the mobile phase. The method showed excellent precision, accuracy and speed with detection limit of 0.01 microgram/ml-1. Total analysis time per sample was less than 20 min and the coefficients of variation for intra and inter-assay were less than 5.63%. This method has been successfully applied to plasma samples from rats after oral administration of omeprazole.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10319158     DOI: 10.1007/bf02979125

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  12 in total

1.  High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine.

Authors:  I Aoki; M Okumura; T Yashiki
Journal:  J Chromatogr       Date:  1991-11-15

2.  Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography.

Authors:  M A Amantea; P K Narang
Journal:  J Chromatogr       Date:  1988-04-08

Review 3.  Clinical pharmacology of omeprazole.

Authors:  C W Howden
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

4.  Oral pharmacokinetics of omeprazole.

Authors:  C W Howden; P A Meredith; J A Forrest; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.

Authors:  T Andersson; K Andrén; C Cederberg; P O Lagerström; P Lundborg; I Skånberg
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

Review 6.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

7.  Simultaneous high-performance liquid chromatographic analysis of omeprazole and its sulphone and sulphide metabolites in human plasma and urine.

Authors:  G W Mihaly; P J Prichard; R A Smallwood; N D Yeomans; W J Louis
Journal:  J Chromatogr       Date:  1983-12-09

8.  Determination of omeprazole and metabolites in plasma and urine by liquid chromatography.

Authors:  P O Lagerström; B A Persson
Journal:  J Chromatogr       Date:  1984-08-10

9.  Pharmacokinetics and metabolism of omeprazole in animals and man--an overview.

Authors:  C G Regårdh; M Gabrielsson; K J Hoffman; I Löfberg; I Skånberg
Journal:  Scand J Gastroenterol Suppl       Date:  1985

10.  Peak distortion in the column liquid chromatographic determination of omeprazole dissolved in borax buffer.

Authors:  T Arvidsson; E Collijn; A M Tivert; L Rosén
Journal:  J Chromatogr       Date:  1991-11-22
View more
  1 in total

1.  Simultaneous Estimation of Esomeprazole and Domperidone by UV Spectrophotometric Method.

Authors:  S Lakshmana Prabu; A Shirwaikar; Annie Shirwaikar; C Dinesh Kumar; A Joseph; R Kumar
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.